Back to Search
DR. ALISON ELIZABETH GOTTLIEB OD
OD
Optometrist
NPI: 1831683069IndividualAccepts Medicare
Specialties, Licenses & Credentials
OptometristPrimary
Optometrist
Code: 152W00000X
TUV008797(NY)
Education
SOUTHERN COLLEGE OF OPTOMETRY
Class of 2018
Clinical Trials (2)
2
Linked Trials
0
Recruiting
2
With Results
Research & Publications (11)
Safety and efficacy of a fixed combination of halobetasol and tazarotene in the treatment of moderate-to-severe plaque psoriasis: Results of 2 phase 3 randomized controlled trials.
PMID 29614243·J Am Acad Dermatol·2018
3-trial
Safety and Efficacy of a Fixed Combination Halobetasol and Tazarotene Lotion in the Treatment of Moderate-to-Severe Plaque Psoriasis: A Pooled Analysis of Two Phase 3 Studies.
PMID 30124724·J Drugs Dermatol·2018
8-other
Secukinumab shows significant efficacy in palmoplantar psoriasis: Results from GESTURE, a randomized controlled trial.
PMID 27707593·J Am Acad Dermatol·2017
3-trial
Palmoplantar Psoriasis and Palmoplantar Pustulosis: Current Treatment and Future Prospects.
PMID 27113059·Am J Clin Dermatol·2016
6-review
CCL20 and IL22 Messenger RNA Expression After Adalimumab vs Methotrexate Treatment of Psoriasis: A Randomized Clinical Trial.
PMID 25946554·JAMA Dermatol·2015
4-observational
Efficacy and safety results from the randomized controlled comparative study of adalimumab vs. methotrexate vs. placebo in patients with psoriasis (CHAMPION).
PMID 18047523·Br J Dermatol·2008
4-observational
Mechanisms of action of etanercept in psoriasis.
PMID 17502868·J Investig Dermatol Symp Proc·2007
6-review
Etanercept induces apoptosis of dermal dendritic cells in psoriatic plaques of responding patients.
PMID 17010737·J Am Acad Dermatol·2006
8-other
Induction of lesional and circulating leukocyte apoptosis by infliximab in a patient with moderate to severe psoriasis.
PMID 17039656·J Drugs Dermatol·2006
5-case
TNF inhibition rapidly down-regulates multiple proinflammatory pathways in psoriasis plaques.
PMID 16081850·J Immunol·2005
8-other
Differential expression of phosphorylated NF-kappaB/RelA in normal and psoriatic epidermis and downregulation of NF-kappaB in response to treatment with etanercept.
PMID 15955104·J Invest Dermatol·2005
3-trial
Data courtesy of the U.S. National Library of Medicine (NLM). Ltrl is not affiliated with or endorsed by NLM.
Contact & Hours
Via practice · 2 locations total
- Address
- 1650 GRAND CONCOURSE
BRONX, NY 10457 - Phone
- (718) 590-1800
Quick Facts
- NPI
- 1831683069
- Entity Type
- Individual
- Gender
- Female
- Medicare
- Accepted
- Specialties
- 1
- Locations
- 2
- Years in Practice
- 8
- Clinical Trials
- 2
- Publications
- 11
Are you this provider?
Claim Your Profile